|
Pipeline & Portfolio Optimization
Optimizing new product opportunities is the cornerstone of value creation in the life sciences industry. At Trinity, we help our clients in their efforts to maximize marketed brands, add new assets and develop new products. We work closely with a wide variety of clients ranging from medical device to diagnostics companies in order to maximize pipeline portfolio opportunities. Our experience includes pre-clinical to phase IV development stages in a wide variety of therapeutic areas (primary care, specialty, devices and diagnostics). The types of engagements that our clients find most valuable for their pipeline assets include:
- Determining and prioritizing therapeutic indications for clinical and commercial development
- Crafting target product profiles and comparing them to current and emerging gold standard treatments
- Assessing market landscapes for new opportunities, include in-depth assessment of unmet needs
- Quantitatively determining optimal resource allocation between various pipeline options
- Monitoring competition
- Positioning through strategic assessments and early commercial input
Major benefits that our clients receive from working with Trinity on pipeline issues include optimizing resources (money, time and people), managing risk, recognizing and taking advantage of new opportunities, and creating a vision of the future by “seeing around corners.”
Questions for Trinity
How do we prioritize pipeline opportunities in a fast-moving specialty market?
Is there a business case for our product that warrants additional investment?
How can we use primary market research with multiple stakeholders to evaluate the commercial value drivers for my technology?
|
